Abstract
Pituitary resistance to thyroid hormone(PRTH) is a kind of autosomal dominant hereditary disease. It is mainly caused by the mutations of the thyroid hormone receptor beta gene. The feature of labora-tory is elevated serum free thyroxine (FT4) and free triiodothyronine (TT3) with inappropriate TSH. 3,5,3'-triiodothyroacetic acid (TRIAC), D-T4, bromocriptine have been used in the therapy of PRTH, however, no radical cure has been found now. Key words: Pituitary resistance to thyroid hormone; Gene mutation; Beta subunit; 3,5,3'-triiodothy-roacetic acid
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
